Ajax-Loading

Astellas Pharma Inc. - Total Long Term Assets

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Total-Long-Term-Assets" stands at 2.08 Trillion Japanese Yens as of 09/30/2025.

As of the end of Astellas Pharma Inc.'s second quarter, the item "Total Long Term Assets" stands at 2.08 Trillion JPY. This represents an increase of 1.91 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.87 percent compared to the value the year prior.
The 1 year change in percent is -7.87.
The 3 year change in percent is 36.53.
The 5 year change in percent is 46.88.
The 10 year change in percent is 154.74.

The Serie's long term average value is 1.18 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 75.84 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 09/30/2025, is +256.32%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -16.57%.

Total Long Term Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Long Term Assets905,699,262,464.00
LogoJohnson & Johnson - Total Long Term Assets486,508,953,600.00
LogoAbbVie Inc - Total Long Term Assets399,570,305,024.00
LogoRoche Holding AG - Total Long Term Assets317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Assets280,205,508,085.11